BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 18, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 29, 2005
View Archived Issues
Potent candidate for EGFR overexpressing tumors identified
Read More
Xanodyne completes acquisition of aaiPharma products
Read More
Novel mGluR1 antagonist evokes analgesia
Read More
Cellzome and Novartis expand pathway research collaboration
Read More
Clinical trials support the use of certolizumab in active Crohn's disease
Read More
Preclinical evidence suggests estrogen receptors play a role in gonadotropin-induced fertility
Read More
Tempol improves dopamine D1 receptor dysfunction in obese rats
Read More
Chunghyuldan lowers systolic blood pressure in stroke patients
Read More
Identification of a potent and selective histamine H4 receptor agonist
Read More
Transkaryotic Therapies stockholders approve acquisition by Shire
Read More
Schering AG and AstraZeneca form antiinflammatory collaboration
Read More
Twinstrand Therapeutics cleared for U.S. clinical development of TST-10088
Read More
Japanese phase I trial of NFkB decoy oligo for atopic dermatitis cleared to begin
Read More
Valeant plans phase III trials for retigabine for partial-onset seizures
Read More
ZARS receives approval for Synera topical local anesthetic patch
Read More
Phase Ib study examines GI-5005 for chronic HCV
Read More
GRN-163L enters clinical trial in CLL patients
Read More
Japanese approval for Finibax
Read More
Allegra-D 24 Hour now available
Read More
Encysive submits Thelin MAA
Read More
Submission of Ranexa NDA amendment
Read More
European CHMP hands down positive opinion for tipranavir
Read More
Fast track designation for TAK-242 for severe sepsis
Read More
NDA accepted for Wyeth's new oral contraceptive
Read More
Novel therapeutics for cardiovascular diseases reported
Read More
Melanocortin MC4 receptor agonists in early development at Novo Nordisk
Read More
Kyoto University discloses novel therapeutic agents for eating disorders
Read More
